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Colony-stimulating factors (CSF)' are a family of glycoproteins that support
the clonal proliferation and differentiation of hematopoietic progenitor cells in
vitro (1-3). As pluripotent stem cells generate committed progenitor cells of a
specific lineage, the number of soluble factors capable of inducing proliferation
and/or differentiation of these cells becomes more restricted. This observation
has allowed CSFs to be broadly classified into either multilineage or lineage-
specific growth factors. Lineage-specific CSFs are those acting on cells capable
of forming only one differentiated cell type (4). Granulocyte-CSF (G-CSF),
macrophage-CSF (M-CSF), or erythropoietin (EPO) are lineage-specific CSFs
that stimulate the proliferation and differentiation of committed progenitor cells
into granulocytes, macrophages, or erythrocytes, respectively (5-7). Multilineage
CSFs are those stimulating primitive multipotent cells that generate more than
one fully differentiated cell type. Granulocyte/macrophage-CSF (G/M-CSF) and
IL-3 (multi-CSF) are two distinct multilineage CSFs that support the proliferation
of a broad distribution of hematopoietic cell types. G/M-CSF can stimulate the
production of mature granulocyte, macrophage, or mixed colonies from bone
marrow progenitor cells (8, 9). It also initiates, but does not sustain, proliferation
of some multipotential erythroid and megakaryocyte precursors (10). IL-3 in-
duces colony formation of multiple cell types in cultures of bone marrow or fetal
liver cells. It supports the growth and/or differentiation of multipotent precursor
cells belonging to both the myeloid and lymphoid lineages as well as more
differentiated progenitor cells belonging to the myeloid lineage (2, 11-15). IL-
3 has also been associated with multiple activities and has been termed burst-
promoting activity (16), mast cell growth factor (17, 18), P cell stimulating factor
(19, 20), and histamine-producing cell-stimulating factor (21) by various investi-
gators.
The broad spectrum of activities associated with IL-3 suggests that it may play
a role in both the self-renewal of multipotent stem cells as well as the growth and
differentiation of committed progeny. However, the mechanism by which IL-3
mediates these processes is not understood. In this report, we have studied the
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growth and differentiation of two IL-3-dependent cell lines, FDC-PI (a myeloid
progenitor) (22) and FL5 .12 (a lymphoid progenitor) (14). FDC-P1 was generated
from normal bone marrow cells cultured in the presence of WEHI-3 conditioned
medium (CM) and appears to represent a cell early in myelomonocytic differen-
tiation (22). FL5.12 was generated from the culture of 13-d fetal liver cells in
the presence of WEHI-3 CM and represents a multipotential B lymphoid pre-
cursor cell since these cells can be induced to generate mature IgM-secreting B
cells committed to several different variable region specificities (14). Both these
clones are nonmalignant since they do not form tumors in nude mice. These
clones can be rendered factor-independent and tumorigenic by retrovirus infec-
tion (23). The response to IL-3 and other hematopoietic CSFs was investigated
among activated and resting cells. A model for the regulation of cell growth and
differentiation by IL-3 as well as other CSFs is presented.
Materials and Methods
Cell Lines.
￿
The IL-3-dependent cell lines, FDC-PI and FL5.12, were maintained in
Iscove's modified Dulbecco's medium (IMDM; E. I . du Pont de Nemours & Co.) supple-
mented with 10% FCS (HyClone Laboratories, Logan, UT) and 10% WEHI-3B(D-) CM
as a source of IL-3. Cell lines were maintained at 37°C in a humidified atmosphere of 5%
COs in air.
Growth Factors.
￿
WEHI-3B(D-) supernatant, which contains IL-3 (24), was stored at
-20'C following centrifugation at 500 g for 15 min and passage through a 0.22-,m filter.
This supernatant, added at 10% (vol/vol) to IMDM containing 10% FCS, will be referred
to as WEHI-3 CM. Recombinant G/M-CSF (mouse) (rG/M-CSF), sp act 5 X 10' CFUs/mg
protein, and purified mouse IL-3 supplied at 5,000 U/ml were obtained from Genzyme
(Boston, MA). One CFU is defined as that amount of growth factor that produces a single
colony from 7.5 X 104 murine bone marrow cells in semisolid medium . These units
correlated with our titration in proliferation assays where 1 U is the amount of factor
required to induce 50% maximal ['H]TdR uptake. Purified human rIL-2 and purified
human rIL-1Q were obtained from E. I. DuPont Co. (Wilmington, DE). Recombinant B
cell stimulatory factor 1 (BSF-1, IL-4) was kindly provided by Dr. Donna Rennick (DNAX,
Palo Alto, CA); and purified natural BSF-1 (IL-4) was kindly provided by Drs. Neal
Roehm and John Cambier (National Jewish Hospital, Denver, CO).
Cell Preparations. FDC-P1 and FL5.12 cells, maintained in WEHI-3 CM or other
CSFs, were harvested during log phase of growth, washed four times in HBSS (pH 7.2),
and replated at 2 X 105 cells/ml in CSF-supplemented or CSF-deficient medium. After a
24-h incubation at 37 °C in 5% COs in air, the cells were harvested, washed four times in
HBSS, and live cells (determined by method described below) were collected by Percoll
(Pharmacia Fine Chemicals, Uppsala, Sweden) density gradient centrifugation. Briefly, 2
X 10' washed cells were resuspended in 3 ml of pH 7.4 isoosmotic Percoll (p = 1 .075). 1
ml HBSS was layered on top and tubes were centrifuged at room temperature for 30 min
at 1,400 g. Cells with p < 1 .075 formed an interface layer between the Percoll and HBSS
and all were shown to be dead by trypan blue dye exclusion. Live cells (typically >98%),
as determined by trypan blue dye exclusion, were harvested from the pelleted fraction (p
> 1 .075). This preparation of cells was subsequently used in all the individual assays
described.
['H]TdR Uptake.
￿
Cell division was measured by resuspending 104 washed, viable cells
in 0.1-ml cultures in 96-well flat-bottomed microtiter plates (Costar, Cambridge, MA).
The plates were then incubated at 37°C in a humidified atmosphere of 5% COs in air.
After the indicated time, triplicate cultures were pulsed with 0.5 ,sCi (sp act 6.7 Ci/mmol;
New England Nuclear, Boston, MA) of ['H]TdR, and harvested 4 h later on glass fiber
filters with an automatic cell harvester (Cambridge Technology Inc., Cambridge, MA).
Results are expressed as mean cpm (± SEM) of ['H]TdR uptake per culture in triplicatew J
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FIGURE 1 . Cell cycle compart-
ments in actively cyclingor factor-
deprived cell lines. FDC-P1 (A
and B) or FL5.12 (C and D) cells,
either actively cycling (A and C)
or 24-h factor-deprived (B and D)
were analyzed for DNA and RNA
content using the dye acridine or-
ange. x-axis, red flourescence in-
tensity, RNA content per cell; y-
axis, green flourescence intensity,
DNA content per cell. Box des-
ignates Go.
groups. In addition, cell number and viability (determined by trypan blue dye exclusion)
were monitiored.
OxidativePhosporylation Enzyme Activity.
￿
Oxidative phosphorylation enzyme levels were
evaluated as previously described (25). Briefly, cells were prepared and plated in the same
manner as for the ['H]TdR uptake assay except that 105 cells were plated per well. After
the indicated time, 0.02 ml of 3(4,5-dimethyl-thiazoyl-2-yl) 2,5-diphenyltetrazolium bro-
mide (MTT; 5 mg/ml in PBS) (Sigma Chemical Co., St. Louis, MO) was added to each
well. Plates were then incubated at 37° C for 4 h. The plates were centrifuged, the
supernatant removed, and 0.1 ml of acid-isopropanol (0.04 N HCI in isopropanol) was
added and mixed. Plates were read on a Flow Multiscan (Flow Laboratories, Inc., McLean,
VA) at a test wavelength of 570 Inn and a reference wavelength of 630 nm.
DNA and RNA Content.
￿
Simultaneous detection of RNA and DNA levels within single
cells was performed using a protocol adapted from Darzynkiewicz et al . (26). Briefly, 106
washed, viable cells were resuspended in 0.2 ml HBSS containing 1 % FCS. 0.4 ml of 0.08
M HCI, 0.15 M NaCI, and 0.1 % Triton X-100 was added, mixed gently, and incubated
for 90 s. Acridine orange solution (12 ,ug/ml) in 0.25 M Na2HPO4, 0.1 M citric acid, 0.2
mM EDTA, and 0.15 M NaCl were then added, and incubated at room temperature,
protected from light, for 20 min. 37% ethanol was added and the samples were analyzed
using a FACS Analyzer (Becton Dickinson & Co., Mountain View, CA) and Consort 30
computer.
Results
Transition to Go ofIL-3-dependent Cell Lines upon Removal ofLigand.
￿
FDC-P1
and FL5.12 cells, maintained in WEHI-3 CM, were harvested, washed in HBSS,
and cultured at 2 X 105 cells/ml in the presence or absence of WEHI-3 CM.
After 24 h, DNA and RNA content of single cells was quantitated by FACS
analysis. During exponential growth phase (Fig. 1, A and C), ^-55, 25, and 20%
of these cells are in the GI , S, and G2 + M phases of the cell cycle, respectively.
However, when these clones were removed from WEHI-3 CM for >20 h (Fig.
1, B and D), >95% of all cells exit from the cell cycle and accumulate in Go. Both1422
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FDC-P1 and FL5.12 cells grow in serum-free medium in the presence ofWEHI-
3 CM. These cells alsoenter Go when deprived ofWEHI-3 CM (data not shown).
We confirmed that such cells were in a resting state by monitoring [3H]TdR
uptake, oxidative phosphorylation enzyme levels (MTT assay), total cell volume,
and number of viable cells. Fig. 2A demonstrates that [3H]TdR uptake begins to
decrease 8 h after removal ofWEHI-3 CM. Both clones reach background levels
of [3H]TdR uptake by 20-24 h of culture. Similarly, oxidative phosphorylation
enzyme levels slow dramatically 4-8 h after removal of WEHI-3 CM (Fig. 2B)
and negligible levels were observed by 24 h of culture. Total cellular volume
measurements determined at 24 h also indicate that a substantial decrease in cell
size had occurred (Fig. 2C). Cells in WEHI-3 CM were 15-17 Am in diameter
and 7-9 Am in diameter when ligand was removed. 50-70% of the cells were
viable 24 h after the removal of WEHI-3 CM (Fig. 2D), and, at 48 h, >50% of
FL5.12 cells remain viable, whereas <10% of FDC-P1 cells are viable. No
significant increase in cell number was observed when WEHI-3 CM wasremoved
from the culture medium.
Activation of Growth-arrested Clones with WEHI-3 CM.
￿
24-h factor-deprived
cells that have accumulated in the Go phase of the cell cycle enter cycle when
cultured in the presence of WEHI-3 CM. For FDC-P1 cells (Fig. 3A), Go to G,
transition occurs between 8 and 12 h, while the G, to S phase transition occurs
by 12 h ofculture. FL5.12 cells (Fig. 3A), move into G, between 4 and 8 h after
factor addition, although S phase transition does not occuruntil ^-20 hofculture.
Concurrent with the entry ofcells into cycle, both [3H]TdR uptake and oxidative
phosphorylation enzyme levels increase. FDC-P1 and FL5.12 cells show a signif-
icant and steady increase in [3H]TdR uptake beginning at 12-16 h of culture
(Fig. 3B), while oxidative phosphorylation enzyme levels increase rapidly after
WEHI-3 CM addition (Fig. 3 C). Cell viability in these restimulated cultures is
maintained at >90% throughout the culture period and a doubling time of-11-
13 h is observed for both cell lines after the initial cell division (Fig. 3D). Both
FDC-P1 and FL5.12 cells maintained in the presence of purified IL-3 behave
similarly to cells maintained in WEHI-3 CM, suggesting that IL-3 is the factor
responsible for cell growth.
[3H]TdR Uptake in IL-3-dependent Clones in Cultures Containing Other
CSFs. Several differentCSFs were evaluated fortheir abilitytostimulate growth
ofeither activated or resting (Go) FDC-P1 or FL5.12 cells. FDC-P1 and FL5.12
cells were maintained long-term in either WEHI-3 CM orpurified IL-3 and their
pattern ofresponsiveness to other growth factors was similar (Table I). We found
that only IL-3 or WEHI-3 CM will support growth of FL5.12 cells (Table I)
whether these cells were actively cycling or resting (Go) cells. These cells do not
uptake [3H]TdR in response to human IL-10, human IL-2, mouse G/M-CSF, or
mouse IL-4. In contrast, actively cycling FDC-PI cells (Table I) respond to
WEHI-3 CM or purified IL-3 as well as G/M-CSF or IL-4. Significant increases
in [3H]TdR uptake in response to WEHI-3 CM or purified IL-3 can be observed
at 8-12 h of culture while G/M-CSF or IL-4 appear to maintain a steady-state
level of [3H]TdR uptake over the 24-h culture period (Fig. 4A). These cells do
not uptake [3H]TdR in response to either IL-1 or human IL-2 and long-term
growth has never been observed under these conditions.W
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￿
Cellular activity in factor-deprived IL-3-dependent cell lines. ['H]TdR uptake (A)
in FDC-P1 (-) and FL5.12 (- --) cells was evaluated over a 24-h culture period in the
presence of (O) medium, or (9) WEHI-3 CM. Oxidative phosphorylation enzyme activity (B)
was measured over a 24-h culture period in FDC-P1 (/) or FL5.12 (p) cells. Cell volume
measurements (C) of actively cycling (-) or 24-h factor-deprived (. . .
￿
) cells were
analyzed. Cell viability wasfollowed in duplicate cultures (D) by trypan blue dyeexclusion in
FDC-P1 (-) or FL5.12 (- - -) cells plated in medium (0) total cells, (Q) viable cells. Data
points represent means of triplicate cultures.
In contrast to activated (G,-->M) FDC-P1 cells, resting (Go) cells grow only in
the presence of WEHI-3 CM or IL-3 (Table I, Fig. 4B). Nearly identical patterns
of [sH]TdR uptake, as described above, were obtained from both cell lines,
whether actively cycling or resting (Go), over a 100-fold (2-200 U/ml) range of
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FIGURE 3.
￿
Exit of cells from Go after readdition of IL-3. FDC-PI and FL5.12 cells were
factor-deprived for 24 h and replated in the presence of WEHI-3 CM. After the indicated
time period, acridine orange staining for analysis of cell cycle compartments was performed
(A). (") Got (") G,, (") S + G4 + M. The kinetics of induction of ['H]TdR uptake (B) and
oxidative phosphorylation enzyme activity (C) in resting (Go) FDC-P1 I(-) or FL5.12
(- - -) cells was followed in the presence of (p) medium, or (") WEHI-3. Cell viability by
trypan blue dyeexclusion (D)was similarly followed in FDC-P1 (-)and FL5.12 (- - -) cells.
(") total cells, (Q) viable cells. Data points represent mean oftriplicate cultures. The SEM was
<15%.LONDON AND McKEARN
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TABLE I
/'HJTdR Uptake by IL-3-dependent Cell Lines in Response to Hernatopoietic Growth Factors
' Either FDC-P1 or FL5.12 cells were maintained in continuous culture in the presence of 10% WEHI-3 CM or 20 U/ml purified IL-3 .
Numbers in parentheses represent thenumber ofexperiments performed .
t FDC-P1 or FL5.12 cells maintained in either WEHI .3 CM or purified IL-3 were harvested, washed four times in HBSS and replated at 2x
10' cells/ml in the presence or absence offactor for 24 h . The cells were then harvested and washed, and live cells were obtained. The cells
were then plated at 10' t cells/well for an additional 24 h in the presence ofvarious factors .
f Cells were plated in the presence of medium alone, 10% WEHI-3 CM, 20 U/ml IL-3, 20 U/ml IL-1, 20 U/ml IL-2, 20 U/ml IL-4, or 20
U/ml of G/M-CSF for 24 h .
1 Numbers represent cpmtSEM of [sH]TdR incorporated during the last 4 h ofculture.
factor concentrations (data not shown) . In addition, similar patterns of [3H]TdR
uptake were observed under serum-free conditions in the presence of WEHI-3
CM or after a 24-h factor starvation (data not shown) .
Analysis of Factors that Cause a Go to G1 Transition in IL-3-dependent Cell
Lines . Resting (Go) FDC-P 1 cells or FL5.12 cells (Fig . 5) were cultured in the
presence of IL-3, IL-4, G/M-CSF, or IL-1 for 12 or 24 h. At these time points,
total cellular RNAcontent per cell was quantitated.We found that IL-3 induced
an increase in total cellular RNA in both FDC-P1 andFL5.12 cells after 12 h of
culture, indicating that a Go to G, transition had occured. By 24 h after IL-3
stimulation, both clones were actively cycling (Fig . 5) . In FDC-P1 cells, IL-4 or
G/M-CSF also caused a Go to G, transition by 12 h of culture. However, IL-4 or
G/M-CSF did not promote entry of resting FDC-P1 cells into S, G2, or M (Figs .
4B, 5) . IL-I (Fig . 5) and IL-2 (data not shown) had no effect on either FDC-P1
or FL5.12 cells at any time during the incubation.
While actively cycling FDC-P1 cells can enter the S phase in response to G/M-
CSF or IL-4, we have shown that resting (Go) cells are unable to enter the S
phase in response to these factors (Table I ; Fig. 4) . This result suggests that IL-
3 may provide an obligatory signal that enables cells to subsequently respond to
G/M-CSF or IL-4 . Therefore, we analyzed the kinetics of the appearance of
responsiveness to these factors in resting (Go) cells pulsed with IL-3 for various
times, washed, and recultured in the presence of various CSFs for an additional
24 h. We found that a minimum of 12 h of incubation with IL-3 was required
before responsiveness to G/M-CSF or IL-4 returned (Fig . 6). As acontrol, resting
(Go) cells preincubated in the presence of either G/M-CSF or IL-4 for 12 h,
although able to enter G,, were unable to enter S phase in response to either
G/M-CSF or IL-4 (data not shown) .
Both G/M-CSF and IL-4 Can Maintain Long-term Growth of FDC-PI
Cells . Stable, long-term cell lines have been established from FDC-P1 cells
Cell Fac- Culture condition
line- tort Medf WEHI-3 CM IL-3 IL-1 IL-2 IL-4 G/M-CSF
FDC-P1 + 765t 399 1 46,619 t 5,355 29,166 t4,948 243t 121 1,507 t204 10,749 t2,903 24,978 t4,083
WEHI-3 CM - 72 t35 19,798 t 2,098 13,254 t3,093 51 t 19 171 t89 1,248t251 1,764 t270
(10)
FDC-P1 + 169t77 32,404 t 4,904 30,436 t7,741 98 t 35 193 t64 13,767 t4,420 11,001 t2.508
IL-3 (6) - 84t45 24,228 t 5,248 21,276 t5,772 33 t 3 34 t 3 885t336 407 t 74
FL5.12 + 612t302 15,063 t 1,707 9,360t3,464 640t 250 720 t265 498t211 667 t249
WEHI-3 CM - 98 t 35 7,408t 2,512 8,182t4,611 347t 219 364 t219 344t278 282 t163
(6)
FL5.12 + 532t60 6,148t 2,060 6,689t2,656 432t 67 508 t 154 541 t254 575 t37
IL-3 (3) - 58 t5 6,040t 2,115 5,414t 1,944 96 t 8 60 t20 64 t 10 52 t9.71426
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FIGURE 5. Determination of a Go
to G, transition induced by various
CSFs in IL-3-dependent cell lines.
Resting (Go) FDC-P1 and FL5.12
cells were incubated in the presence
of 20 U/ml 1L-3, IL-4, G/M-CSF, or
IL-1 for 12 (- - -) or 24 (-) h,
after which acridine orange staining
for RNA content was performed.
(. . . ) RNA content at time 0. y-
axis, relative cellsnumber; x-axis, flu-
orescence intensity, RNA content
percell.
maintained in the presence of either G/M-CSF or IL-4. To determine whether
these cells behave similarly to the cells from which they were derived, the lines
were deprived ofthe respective CSF for 24 h. Unlike FDC-PI cells maintained
in either WEHI-3 CM or purified IL-3, FDC-P1 cells adapted for growth in
either G/M-CSFor IL-4 did not makeacompletetransition into Go. The majority
of cells accumulated in G, (Fig. 7). This observation was also confirmed when
CSF-deprived cells, restimulated with their respective ligand, quickly progress
through G, and rapidly enter S, G2 + M (assessed by [sH]TdR uptake and flow
cytometry) by 8-12 h ofculture (not shown).
The finding that FDC-P1 cells maintained in either G/M-CSF or IL-4 were
unable to enter Go upon factor removal showed that these cells had altered their
growth pattern. We subsequently tested whether such cells might respond
differently to other CSF than FDC-P1 cells maintained in IL-3. To investigate
this possibility, a panel ofCSF were analyzed for their ability to stimulate growth
of either cycling or factor-deprived FDC-P1 cells maintained in either G/M-CSF
or IL-4. We found that FDC-P1 cells maintained in G/M-CSF will uptake [sH]-1428
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￿
Kinetics of induction of fH]TdR uptake in response to G/M-CSF or IL-4 in
resting(Go) FDC-PI cells. Resting(Go)FDC-PI cellswere replated in thepresence of 20 U/ml
of IL-3 for the indicated time period, washed free of IL-3 and replated in the presence of (0)
WEHI-3 CM, (O) 20 U/ml IL-3, (A) 20 U/ml IL-4, (A) 20 U/ml G/M-CSF, or (p) medium
for an additional 24 h. Data points represent the mean of triplicate cultures. The SEM was
<15%.
TdR in response to WEHI-3 CM, IL-3, IL-4, or G/M-CSF with similar kinetics
over a 24-h culture period whether these cells were actively cycling (Fig. 8A) or
24 h factor-deprived (Fig. 8B). Therefore, these cells behave differently than
cells maintained in IL-3, which lose their ability to enter S phase in response to
other CSF when factor-deprived (Fig. 4; Table 1). FDC-P1 cells maintained in
IL-4 will uptake [3H]TdR in response to either WEHI-3 CM, IL-3, or IL-4
whether or not they have been factor-deprived for 24 h (Fig. 8, C and D).
However, unlike the cells from which they were derived, these cells lose their
ability to respond to G/M-CSF. These results clearly demonstrate that FDC-PI
cells maintained in either G/M-CSF or IL-4 are altered in their growth factor
responsiveness.
Discussion
The regulation of hematopoietic cellular growth and differentiation involves
a complex set of interactions between hematopoietic stem cells and the microen-
vironment in which they reside. This process enables multipotential hemato-
poietic stem cells to generate all mature cells ofthe hematopoietic lineages. Stem
cells are defined by their extensive proliferative capacity, their ability to differ-
entiate along multiple lineages, and their ability to undergo self-renewal (27-w J Q U N
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FIGURE 7.
￿
Cell cycle compartments in FDC-P1 cells maintained in G/M-CSF or IL-4. FDC-
P1 cells maintained in G/M-CSF (A and B) or IL-4 (C and D) were analyzed for DNA and
RNA content using acridine orange. Either actively cycling (A and C) or 24-h factor-deprived
(B and D) cells were used. x-axis, red fluorescence intensity, RNA content per cell; y-axis,
green fluorescence intensity, DNA content per cell. Box designates Go.
29). Presently, the mechanisms that regulate the growth and differentiation of
these pluripotent stem cells are not completely understood.
Two major models have been proposed for the mechanism of stem cell renewal
and commitment. The deterministic model of stem cell development suggests
that the commitment of pluripotent hematopoietic stem cells to committed
progenitors is regulated by the immediate microenvironment of the individual
stem cell (30, 31). Appropriate external stimuli would act directly on stem cells
to control commitment resulting in a uniform response to environmental stimuli.
In contrast, the stochastic model of stem cell development predicts that multi-
potential stem cell differentiation is dependent upon different intrinsic probabil-
ities that can be assigned to each of the hematopoietic lineages (32). These
probabilities determine the likelihood of commitment to a specific lineage, with
further commitment ofprogenitor cellsbeing governed by progressive restriction
in their differentiation potentials (33). External growth factors would determine
which hematopoietic lineage can be derived from multipotential cells by influ-
encing only the probability of such an event occurring within a self-renewing
pool of stem cells rather than causing commitment of individual stem cells to a
particular lineage (30, 34, 35). These growth factors have been classified as1430
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￿
[sH]TdR uptake by FDC-PI cells maintained in G/M-CSF or IL-4 in response to
various CSFs. FDC-PI cells maintained in G/M-CSF(A andB) or IL-4 (C andD), either actively
cycling (A and C) or 24-h factor-starved (B and D), were analyzed for their response to (O)
medium, (0) WEHI-3 CM, (O) 20 U/ml IL-3, (A) 20 U/ml G/M-CSF, or (A) 20 U/ml IL-4 by
['H]TdR uptake. Data points represent the mean of triplicate cultures. The SEM was<15%.
either competence or progression factors, depending on the phase of the cell
cycle where they are active (34). Competence factors might be regulators that
act oncells in Goandallow them to enter GI. Progression factors would influence
cells after interaction with a competence factor and cause these cells to traverse
into S, G2, and M. Competence factors may regulate the cells responsiveness to
a progression factor by up- or downregulating corresponding growth factor
receptors or effecting an intrinsic change among cells recognizing such factors.
Thus, it has been suggested that a hierarchy of growth factor responsiveness
functionally controls different stages ofmaturation (36). This model implies thatLONDON AND McKEARN
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as a cell matures, it loses its responsiveness to one factor and gains the ability to
respond to another.
We have used two IL-3-dependent hematopoietic progenitor clones, FDC-P1
(a myeloid progenitor) and FL5.12 (a lymphoid progenitor), as a model for the
regulation ofcell cycle progression in hematopoietic stem cells. The metachro-
matic fluorochrome acridine orange was used to differentially stain single- versus
double-stranded nucleic acids, thus identifying the various phases of the cell
cycle. After selective denaturation ofdsRNA, cellular DNA and RNA arestained
differentially allowing for the discrimination between cells with different RNA
content for a given DNA content (26, 37). It is possible to discriminate between
cells in G,, S, and G2 + M phases of the cell cycle based on differences in their
green flourescence (DNAcontent). Further, one candistinguish two qualitatively
different compartments ofG, according to RNA content, G,A (early G,) and G,B
(late G,). The threshold dividing the A and B compartments represents the
minimal RNA content of S phase cells, although the distribution of G, phase
cells is unimodal with respect to RNA content (37). Actively cycling cells are
fully separated from quiescent (Go) cells based on total cellular RNA content.
All quiescent cells have a 2N DNA contentand very low RNA content, distinctly
lower than G,A cells, such that no overlap in RNA content is observed between
Go cells and cells growing exponentially (37). We found that both FDC-P1 and
FL5.12 cells, when deprived of IL-3, could be synchronized in the Go phase of
the cell cycle. Accumulation ofcells in the Go (resting) compartment was corrob-
orated by direct measurement of RNA and DNA levels within single cells,
background levels of both [sH]TdR uptake and oxidative phosphorylation en-
zyme levels, as well as a significant decrease in cell volume . Furthermore, 24 h
after factor deprivation, 50-70% ofthe cells remain viable. This finding indicates
that the majority ofcells, rather than a small subpopulation, reach Go before cell
death occurs. Upon readdition ofIL-3, these factor-deprivedlines synchronously
enter G, and ultimately progress through the S, G2, and M phases of the cell
cycle. Therefore, these results have clearly shown that IL-3 is a competence
factor acting on a cell in Go and allowing it to progress into G,. If exposure to
IL-3 persists, it functions as a progression factor, allowing cells to traverse from
G, into S, G2, and M.
The pivotal role that IL-3 plays in hematopoietic development is shown by the
ability of IL-3 to regulate responsiveness to other hematopoietic growth factors.
This was demonstrated in FDC-P1 cells that were deprived of IL-3 and accu-
mulated in Go. These cells do not proliferate in response to G/M-CSF or IL-4.
However, when they reenter G, in the presence of IL-3, growth in response to
G/M-CSF orIL-4 is observed . These data would indicate thatIL-3 can upregulate
either the specific receptors for G/M-CSF or IL-4, or a closely related structure
necessary for receptor signaling. These results are in contrast to those reported
by Walker and coworkers (36). They suggest that the activity ofIL-3 (multi-CSF)
could be attributed to its ability to downregulate and thus activate other growth
factor receptors. Since their experiments were performed using total bone
marrow cells, the assignment of these different CSF receptors to a single class of
cells was not possible. The use in our system ofa clonal population ofcells allows
us to investigate ligand-receptor interactions on a clonal level. The generation1432
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ofa larger panel ofhematopoietic progenitor cells, dependent upon IL-3 and/or
other CSFs, as well as the development of receptor binding assays, will allow us
to determine whether the responsiveness observed in FDC-P1 cells is a general
phenomonen.
We have also found that either G/M-CSF or IL-4 can maintain long-term
growth of FDC-PI cells. In the presence of either G/M-CSF or IL-4, a striking
change inthe regulation ofcell cycle progression occurs. Upon removal offactor,
these cells accumulate in G, rather then Go. This observation is corroborated by
the functional ability of FDC-P1 cells maintained in G/M-CSF or IL-4 to
proliferate in response to the same panel of CSFs that they respond to when not
factor-deprived. In addition, FDC-PI cells maintained in IL-4 are further distin-
guished by the loss of their ability to grow in response to G/M-CSF.
The significance of these findings in relationship to normal pluripotent stem
cell development in vivo is corroborated by the recent finding (38) that most
multipotent stem cells in vivo reside in the resting (Go) state. Upon appropriate
stimulation, these quiescent stem cells generate mature cells ofall the hemato-
poietic lineages. In our system, CSF deprivation results in the accumulation of
IL-3 dependent clones in Go. However, these resting (Go) cells still remain
responsive to IL-3 and upon stimulation, enter G,. At this point, cell growth can
be initiated after stimulation with appropriate CSF. IL-3 can provide the neces-
sary signal for Go-+G, transition and when sufficient levels of exogenous IL-3
are present, cells can transit from G,--+M in 11-13 h. This pattern of growth
can be maintained in vitro long term. Some IL-3-responsive cells (e.g., FDC-PI)
can respond to other CSFs. However, cell growth supported by other CSFs could
only be accomplished when cells reside in or beyond late G, or early S phase (8-
12 h after IL-3 stimulation (Figs. 5 and 6). Maintenance of subsequent cell
growth by other CSFs (G/M-CSF or IL-4) was not dependent upon exogenous
IL-3 during G, phase and such cells did not transit to Go when depleted of G/M-
CSF or IL-4. Loss of IL-3 dependence, failure to exit cell cycle to Go, functional
specialization, as well as striking changes in morphology and cell surface pheno-
type were observed when FDC-P1 cells were grown in G/M-CSF or IL-4.
The manner in which IL-3 regulates growth by supporting self-renewal and
rendering some cells competent to long-term growth in response to additional
CSFs provides strong clues to the biology of hematopoietic stem cells. Our in
vitro model may mimic many features that result in assymetric division ofstem
cells (self-renewal coordinated with generation of differentiated progeny) and
the ability of stem cells to reside for some time in Go. Indeed, normal hemato-
poiesis may occur through the sequential utilization ofdifferent stem cell clones
(38, 39). Recruitment of such clones from a "cryptic" or resting state and their
subsequent differentiation program may be dependent upon the stage of cell
cycle as well as sequential changes induced by CSF.
Summary
Hematopoietic cell development is regulated by a series ofgrowth factors that
are progressively restricted in their biological activity. IL-3 is a multi-lineage
growth factor that supports the growth and differentiation of progenitor cellsLONDON AND McKEARN
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belonging to multiple lineages. However, the mechanism by which IL-3 induces
proliferation and differentiation of these cells is not completely understood.
In this report, we have used two IL-3-dependent cell lines, FDC-P1 (a myeloid
progenitor) and F15 .12 (a lymphoid progenitor) to investigate IL-3-mediated
growth and differentiation. When either FDC-P1 or FL5.12 cells are deprived
of IL-3, >90% of all cells accumulate in the Go phase of the cell cycle. Upon
readdition of IL-3, the cells will reenter the active phases of the cell cycle .
Therefore, IL-3 can act as both a competence (Go->Gl) factor, and a progression
(G,--*M) factor for hematopoietic precursor clones.
FDC-P 1 cells can also proliferate in response to granulocyte/macrophage
colony-stimulating factor (G/M-CSF) and IL-4 (B cell stimulatory factor 1 [BSF-
1 ]). However, resting (Go) FDC-P 1 cells have lost their ability to grow in response
to both G/M-CSF and IL-4, even though both factors can induce a Go-->Gl
transition. Therefore, G/M-CSF or IL-4 behave as progression factors among
certain IL-3-responsive clones, and in those cases only in defined points in the
cell cycle.
Both IL-4 and G/M-CSF can maintain long-term growth of FDC-P1 cells.
Upon removal of factor for 24 h, these clones accumulate in the G, phase of the
cell cycle and do not appear to enter Go even after 36 h of factor deprivation.
Therefore, cells maintained in G/M-CSF or IL-4 have altered growth require-
ments compared with the IL-3-dependent lines from which they were derived.
The ability of various hematopoietic growth factors to regulate cell cycle pro-
gression in IL-3-dependent cell lines is dependent not only upon the lineage
from which these cells were derived, but also the phase of the cell cycle in which
those cells reside. The consequences of these interactions dictate the manner by
which various clones will respond to CSFs and whether the cells will grow and/or
differentiate.
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